Stay updated on Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. This appears to be a minor site revision.
    Difference
    0.1%
    Check dated 2026-02-12T02:18:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:33.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added glossary display option; added metadata labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T20:25:18.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4; there are no changes to study details, dates, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:07:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing California, Massachusetts, and New York; removed separate state location headers and updated the revision from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T21:15:22.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Publications section updated to indicate items are automatically filled from PubMed. Revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:47:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.